Literature DB >> 29199877

The duration of hyaluronidase and optimal timing of hyaluronic acid (HA) filler reinjection after hyaluronidase injection.

H J Kim1, S B Kwon2, K U Whang2, J S Lee3, Y L Park4, S Y Lee3.   

Abstract

BACKGROUND: Hyaluronidase injection is a commonly performed treatment for overcorrection or misplacement of hyaluronic acid (HA) filler. Many patients often wants the HA filler reinjection after the use of hyaluronidase, though the optimal timing of reinjection of HA filler still remains unknown.
OBJECTIVES: To provide the optimal time interval between hyaluronidase injections and HA filler reinjections.
METHODS: 6 Sprague-Dawley rats were injected with single monophasic HA filler. 1 week after injection, the injected sites were treated with hyaluronidase. Then, HA fillers were reinjected sequentially with differing time intervals from 30 minutes to 14 days. 1 hour after the reinjection of the last HA filler, all injection sites were excised for histologic evaluation.
RESULTS: 3 hours after reinjection of HA filler, the appearance of filler material became evident again, retaining its shape and volume. 6 hours after reinjection, the filler materials restored almost its original volume and there were no significant differences from the positive control.
CONCLUSIONS: Our data suggest that the hyaluronidase loses its effect in dermis and subcutaneous tissue within 3-6 hours after the injection and successful engraftment of reinjected HA filler can be accomplished 6 hours after the injection.

Entities:  

Keywords:  HA filler; hyaluronic acid filler; hyaluronidase

Mesh:

Substances:

Year:  2017        PMID: 29199877     DOI: 10.1080/14764172.2017.1293825

Source DB:  PubMed          Journal:  J Cosmet Laser Ther        ISSN: 1476-4172            Impact factor:   2.247


  3 in total

1.  Hyaluronidase: An overview of its properties, applications, and side effects.

Authors:  Hyunwook Jung
Journal:  Arch Plast Surg       Date:  2020-07-15

2.  Early hyaluronidase use in preventing skin necrosis after treatment with dermal fillers: Report of two cases.

Authors:  Francesco Ciancio; Maria Stella Tarico; Giuseppe Giudice; Rosario Emanuele Perrotta
Journal:  F1000Res       Date:  2018-09-03

Review 3.  Bridging a Century-Old Problem: The Pathophysiology and Molecular Mechanisms of HA Filler-Induced Vascular Occlusion (FIVO)-Implications for Therapeutic Interventions.

Authors:  Danny J Soares
Journal:  Molecules       Date:  2022-08-24       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.